Navigation Links
LSUHSC researchers working to prevent diabetic neuropathy
Date:9/22/2009

New Orleans, LA Dennis Paul, PhD, Associate Professor of Pharmacology, and Harry Gould, MD, PhD, the Tom Benson Professor of Neurology at LSU Health Sciences Center New Orleans, have been awarded one of two scientific research grants made in 2009 by The Neuropathy Association. The $80,000 grant will fund research to learn how to prevent nerve cell death in people with uncontrolled or untreated diabetes resulting in neuropathy.

In these patients, an enzyme called sodium potassium ATPase, know as the sodium pump because it pumps excess sodium ions out of the cell, does not work. When inflammation occurs, it triggers an increase in the number and sensitivity of sodium channels in the nerve cell membrane causing an influx of sodium with no way to get rid of it. Water follows the sodium into the nerve cells, causing swelling until the cells burst, a process called lysis.

Drs. Paul and Gould believe that by studying the role of nerve cell death by lysis, they can contribute a better understanding of how diabetic neuropathy develops, leading to better ways to influence the process.

"Understanding the mechanism of nerve cell survival after inflammatory or neuropathic insult will lead to new treatment and prevention strategies for diabetic neuropathy," says Dr. Paul.

The LSUHSC research team was chosen from thirteen applicants involved in neuropathy research at medical institutions across North America.

"We continue to invest in critical research that builds on our understanding of neuropathy's many forms, hopeful that our investments will lead to more effective treatment options and cures," says Thomas H. Brannagan, III, MD, Medical Advisor for The Neuropathy Association.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1

Related biology news :

1. LSUHSC awarded $10M+ COBRE grant
2. LSUHSCs Lazartigues awarded $1.2 million grant
3. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
4. LSUHSC awarded patent for compound inhibiting cancer and other diseases
5. LSUHSC research identifies key contributor to Alzheimers disease process
6. LSUHSC student awarded top national honor for diabetes research
7. LSUHSC public health researcher finds reason for weight gain
8. LSUHSC research describes function of key protein in cancer spread
9. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
10. LSUHSC research helps link schizophrenia to specific DNA region
11. LSUHSCs Bazan awarded ARRA grant to preserve vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... ... portfolio company, today announced it has acquired the assets of Theorem Clinical ... International and focuses on clinical trial drug packaging, labeling, storage, reconciliation, and ...
(Date:12/6/2016)... Ind. , Dec. 6, 2016 Zimmer ... "Company") today announced the pricing terms of its ... to $1.25 billion aggregate purchase price (excluding accrued and ... settlement date and excluding fees and expenses related ... the debt securities identified in the table below ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
Breaking Biology Technology: